• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

7
1

CATEGORIES

  • 8
  • 8
  • 5
  • 2
  • 2

PRICE

0
5
7
14

PUBLISHED

1
1
1
14

PRODUCT TYPE

14

Search "Emerging Opportunities in Biosimilar and Biobetter Drugs Markets" returned 14 results.

Biobetters in Key Markets - Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk and High Value Offerings

GBI Research, the leading business intelligence provider, has released its latest research on, “Biobetters in Key Markets - Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk...

July 2012
FROM
Generics/Biosimilars Collection Generics/Biosimilars Collection - Product Thumbnail Image

Generics/Biosimilars Collection

Dossier Report Collections The authors are pleased to showcase Report Collections, focused on areas of critical importance to Pharma's success, present and future These Collections deliver expert views,...

November 2013
FROM

Global Biosimilars Market, 2015 - 2025

Characterised by increased utility in chronic diseases and capital intensive manufacturing, the global biopharmaceutical market is expanding robustly. As the demand for biologics is increasing continuously,...

July 2015
FROM

Biosimilars and Biobetters: Positioning for a New Market 2009

As regulatory frameworks for biosimilars development begin to take shape worldwide, there are growing opportunities for generics companies to enter the biologics market, a segment which is uniquely...

July 2009

Biosimilars and Biobetters: Positioning for a New Market

As regulatory frameworks for biosimilars development begin to take shape worldwide, there are growing opportunities for generics companies to enter the biologics market, a segment which is uniquely...

July 2009

Biosimilar Drugs in Europe: Threat or Opportunity to Innovation?

Between now and 2019, a vast range of blockbuster drugs will go off patent, opening the floodgates in the EU to the biosimilars market Already established there since 2006, biosimilars are set to be...

November 2011
FROM

Biologics and Biosimilars World Markets

Biologics are complex molecules manufactured through cell culture recombinant DNA technology Biologics additionally comprise recombinant insulin, growth hormone and monoclonal antibodies for treating...

August 2013
FROM

Biosimilar Opportunities in an Evolving Market

The long awaited promise of biosimilars takes another step to fulfilment with the first approval in Europe of high-value second generation products But what products can be expected to follow, who is...

August 2013
FROM

The New Generation of Antibody Therapeutics: Current Status and Future Prospects

Antibody sales are predicted to reach $50 billion this year. This report focuses on recent developments in the therapeutic antibody field and new technologies built on the foundations of previously...

June 2012
FROM

The New Trends of Global Biomanufacturing Outsourcing

The fast growth of the global bio-pharmaceutical market has prompted all global major pharmaceutical companies to increase their R&D investment in biologics. The increasing availability of funding opportunities...

July 2014
FROM

Growth Strategies for Supergenerics Organizations - Opportunities in Addressing Unmet Medical Needs and Providing Cost-Effective Solutions for Product Development in Emerging Markets

GBI Research, a leading business intelligence provider, has released its latest research “Growth Strategies for Supergenerics Organizations - Opportunities in Addressing Unmet Medical Needs and Providing...

April 2012
FROM

Fc Protein and Glycoengineered Antibodies Market, 2013 - 2023

Engineered antibodies are antibody based therapeutics, which are gaining increasing attention from both large and small pharmaceutical companies Developed through introduction of modifications in monoclonal...

September 2013
FROM

Biosimilars

In an environment where resources are scarce and patents are fast expiring, effective product planning is paramount to ensuring the success of your organisation Biologic drugs - noted as some of the...

March 2010
FROM

Global Biotechnology Market

Biotechnology has become the foundation on which the pharmaceutical industry and many others are progressing on. The biotech revolution has surpassed the IT revolution as well and has become the new...

October 2012
FROM
Loading Indicator

Our Clients

Innocent Drinks Ltd. Groupe Danone Cisco Systems, Inc. The World Bank Group Swarovski AG Owens Corning Corporation Swiss Reinsurance Company Ltd.